About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline



63 Food & Drug L.J. [i] (2008)

handle is hein.journals/foodlj63 and id is 1 raw text is: FOOD AND DRUG LAW JOURNAL
VOLUME 63                               ISSUE 1                                 2008
CONTENTS
R eports  to  the  R eader  ...................................................................................................... i
To Ban or Not to Ban-That Is the Question:
The Constitutionality of a Moratorium on
Consumer Drug Advertising .......................................................... M ark  I. Schwartz  1
The Regulation of Sanitary Food Transportation in
the United States: A Slow Journey on a Long Road ........................ Julia Ariel Miller  35
The Interoperable Electronic Health Record:
Preserving its Promise by Recognizing and
Limiting Physician Liability ................................................... Shana Campbell Jones  75
Joseph M. McMenamin
David C. Kibbe
Nanosilver: A Test for Nanotech Regulation ..................................... Brian Wilhelmi  89
European Union Food Labeling and Packaging:
The N eed  to  Strike  a  Balance ...................................................................... Jon  Felce  113
Mandatory Labeling of Food Made from Cloned
Animals: Grappling with Moral Objections to
the Protection  of Safe Products ......................................................... Jon  F. M urphy  131
A Global View of the First Amendment Constraints
on  FD A   .................................................................................. K rista  H essler  C arver  151
FDXs Emergency Research Rule: An Inch Given,
a  Yard  Taken ............................................................................... G ail E. G illenwater  217
American Beauty: An Analytical View of the Past
and Current Effectiveness of Cosmetic Safety
Regulations and Future Direction ............................................... Roseann B. Termini 257
Leah Tressler
Pharmaceutical Patent Life-Cycle Management
after KSR  v. Teleflex ................................................................ M ichael Enzo  Furrow  275
Reverse-FOIA Limitations on Agency Actions
to Disclose Human Gene Therapy Clinical Data .............................. Evan Diamond  321
Plan BTC: The Case for a Third Class of Drugs
in  the  U nited  States ............................................................................. D aniel H ealey  375